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Purpose: To evaluate the feasibility of spectral editing for quantification of c-aminobutyric acid (GABA) in the rat brain
and to determine whether altered GABA concentration in the ventral striatum is a neural endophenotype associated
with trait-like impulsive behavior.
Materials and Methods: Spectra were acquired at 4.7T for 23 male Lister-hooded rats that had been previously
screened for extremely low and high impulsivity phenotypes on an automated behavioral task (n511 low-impulsive;
n5 12 high-impulsive). Voxels of 3373 4mm3 (84lL) centered bilaterally across the ventral striatum were used to eval-
uate GABA concentration ratios.
Results: Quantifiable GABA signals in the ventral striatum were obtained for all rats. Mean-edited GABA to n-acetyl aspartate
(NAA) ratios in the ventral striatum were 0.22 (95% confidence interval [CI] [0.18, 0.25]). Mean GABA/NAA ratios in this region
were significantly decreased by 28% in high-impulsive rats compared to low-impulsive rats (P50.02; 95% CI [–53%, –2%]).
Conclusion: These findings demonstrate that spectral editing at 4.7T is a feasible method to assess in vivo GABA concentra-
tions in the rat brain. The results show that diminished GABA content in the ventral striatum may be a neural endophenotype
associated with impulsivity.
J. MAGN. RESON. IMAGING 2016;43:1308–1312.
Gamma-aminobutyric acid (GABA) is a key amino acid inthe brain mediating fast inhibitory neurotransmission.1
Perturbation in GABAergic transmission has been widely impli-
cated in epilepsy and other brain disorders.2–4 However, the
quantification of GABA by noninvasive magnetic resonance
spectroscopy (MRS) is hampered by its low concentration in
the brain and overlapping signals from other metabolites, nota-
bly creatine at 3.0 ppm with an 10-fold greater abundance in
brain tissue.5
Efforts to measure GABA in vivo have included short
echo time sequences, 2D J-resolved spectroscopy, and spectral
editing sequences, the most widely used of which is Mescher-
Garwood point-resolved spectroscopy, or MEGA-PRESS.5,6
The 1H spectrum of GABA (H3N-CH2-CH2-CH2-COO
-) has
three multiplets at 1.9ppm, 2.3ppm, and 3.0ppm, which
overlap with n-acetylaspartate (NAA), glutamine/glutamate, and
creatine, respectively. In MEGA-PRESS, selective saturation of
the GABA methylene protons at 1.9 ppm affects the coupled
GABA spins at 3 ppm, while the uncoupled creatine resonance
at 3ppm is not affected by editing. Thus, subtracting the uned-
ited from the edited spectrum yields a GABA resonance with-
out overlapping creatine signal. For details of MEGA-PRESS
acquisition, see Refs. 6–8.
The present study investigated the feasibility and utility
of MEGA-PRESS at 4.7T for resolving regional GABA
content in the rat brain.
Materials and Methods
Behavioral Screening
Male Lister-hooded rats (n5 96) were screened for impulsivity on the
five choice serial reaction time task (5-CSRTT).9 Briefly, rats were
trained in an operant chamber (Med Associates, USA) to detect the
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location of brief (700msec), spatially unpredictable, visual stimuli pre-
sented on a discrete trial basis in one of five open recesses.10 If the rat
selected the correctly illuminated recess, a 45mg food pellet was deliv-
ered to a magazine in the chamber. If the rat did not respond or
selected an incorrect opening, the chamber lights were switched off for
5 seconds and no food pellet was dispensed. A premature response (ie,
a response made before the onset of the imperative signal to respond)
triggered the same outcome as an incorrect response, with no food pel-
let delivered on that trial. Once rats had acquired the task over 4
months of training, they were screened for impulsivity over a 3-week
period. Rats underwent 100 trials in the apparatus on days 1, 2, 4, and
5, with an intertrial interval (the interval marking the start of the trial
and onset of the light stimulus) of 5 seconds. On day 3 the intertrial
interval was extended to 7 seconds as a deliberate challenge to increase
the number of premature responses.11 Mean rates of premature
responses over the three challenge sessions were used to define rats as
either highly impulsive (a mean number of premature responses 50)
or weakly impulsive (average premature responses 30). The 12 rats
with the highest rates of premature responses and 12 rats with the low-
est rates of premature responses were selected as “high impulsivity
(HI)” and “low impulsivity (LI)” groups, respectively.
All experimental procedures were reviewed and approved by a
local Ethical Review Committee and were conducted in compliance
with appropriate regulatory requirements.
MEGA-PRESS Acquisition
A series of in vitro samples containing GABA (Sigma Aldrich, St.
Louis, MO) in distilled water (0.5, 1.0, 2.0, 5.0, and 10mM) were
scanned to confirm that our implementation of the sequence was
correct and gave values corresponding to known concentrations.
Rats were anesthetized with isoflurane (1.5–2.5% in 1L/min
medical O2). For physiological monitoring, respiration rates were
measured with a pressure sensor, body temperature was measured
with a rectal probe, and oxygen saturation with pulse oximetry
(SA Instruments, New York, NY). Anesthetic dose rates were
adjusted to keep respiration rates within an appropriate physiologi-
cal range and a flowing water heating pad was used to maintain
body temperature throughout the scan.
A Bruker BioSpec 47/40 4.7T system with ParaVision 5.1
(Bruker, Germany) was used with a 72mm birdcage transmit coil
(Bruker model T2000) and manufacturer-provided four-channel
receive array for reception (Bruker model T13014). For placement
of the voxel, localizer and rapid acquisition with relaxation
enhancement images were acquired (repetition time 15.3 sec, effec-
tive echo time 36msec, echo train length 8, field of view
643 64mm2, matrix 2563 256 for 250 lm planar resolution
with 250lm slice thickness in 6min 7 sec).
MEGA pulses were applied at offsets of 1.9 ppm and
7.5 ppm on alternate acquisitions, based on the MEGA-PRESS
sequence with TE15 12msec and TE25 56msec. Gaussian pulses
of 20msec duration were used. Spoiler gradients of 370mT/m
were applied for 1msec in the scheme proposed previously.6 Water
suppression was manually adjusted for each subject using variable
power and optimized relaxation delays (VAPOR).12 The
manufacturer-provided map shim method was used to adjust shim
currents calculated from a measured field map.
The repetition time was 2 seconds and echo time was
68msec. For acquisition, 2048 points were acquired in 511msec
(bandwidth 4 kHz corresponding to 20 ppm). A total of 256 tran-
sients were obtained (128 “on” and 128 “off”) for an acquisition
time of 8 minutes 32 seconds per animal. Water reference scans
were acquired in a single shot for reference prior to each acquisi-
tion to calibrate the phase of the array coil elements.
Spectral Processing and Analysis
Raw data were processed in MatLab 2011b (MathWorks, Natick,
MA). A circular shift of 68 points was applied to the raw data to
compensate for the digitization group delay and data were zero-filled
FIGURE 1: Typical GABA solution spectra for MEGA-PRESS “off” (A), MEGA-PRESS “on” (B), and difference spectrum (C). Plot in
(D) shows the ratio of the GABA peak area at 3ppm to the unsuppressed water peak against prepared concentration showing
good agreement.
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to 8192 points with line-broadening of 3Hz. To correct frequency
and phase drift between transients and identify corruption by motion
or physiological disturbance, the creatine peak from each transient
was fitted and the parameters used to correct or reject entirely the
transient. This was done by first calculating mean “on” and “off”
spectra to obtain the mean values of frequency and linewidth for the
creatine peak at 3.0 ppm. These values were then used to initialize
linear least-squares fitting for the same parameters in each transient
separately. Transients were excluded if the frequency of the peak fit-
ted at 3.0 ppm differed by more than 4 SD (standard deviation) of
the median value, or where the full width half maximum or phase
differed by more than 2 SD of their median values, respectively.
The fitted Lorentzian parameters were used to adjust the fre-
quency and phase of each transient before averaging to produce
mean “on” and “off” spectra. To obtain GABA/NAA ratios, the
NAA peak at 2.0 ppm was fitted to a Lorentzian function and the
GABA peak at 3.0 ppm was fitted to a single Gaussian function.13
Statistical Analysis
The fitted Lorentzian peak areas were compared between HI and
LI animals using Student’s t-test. One-sided tests were used to
compare the null hypothesis with the a priori hypothesis that HI
rats would show reduced GABA ratios compared to LI rats with
P< 0.05 used as the threshold for statistical significance.
Results
In vitro results are shown in Fig. 1. Good agreement was
observed between prepared GABA standards and the signal
measured (R25 0.998) and the spectra “on,” “off,” and
edited difference spectra have the expected form. Illustrative
voxel placement is shown in Fig. 2, with in vivo acquisition
spectra shown in Fig. 3. For clearer presentation, line broad-
ening of 7.5Hz was applied to the edited spectrum and is
shown with an expanded scale. One LI rat did not recover
from anesthesia. As a precaution, data from that subject
were not processed or considered further in the analysis.
Good shimming was achieved for all rats with unsup-
pressed water linewidths below 10Hz (the mean6 SD across
all measured spectra here was 7.56 1.1Hz, full-width half-
maximum). On average, 13 transients were discarded from
each series (SD 2.1) due to frequency drifts, excessive line-
width or phase shifts. Typical frequency drift was 3Hz
(0.015 ppm). Figure 4 shows typical single transients that
were accepted (A), rejected (B) and the mean MEGA-PRESS
“off” spectrum for comparison (C).
Figure 5A shows the screening data used to segregate LI
and HI rats according to the number of premature responses eli-
cited during the three challenge sessions involving an extended
waiting interval between the start of the trial and subsequent
presentation of the light stimulus. It can be seen that HI rats
made consistently more premature responses than LI rats across
each of the three challenge days. Group-averaged concentration
ratios for LI and HI rats are shown in Fig. 5B, with HI rats
exhibiting a 28% lower GABA/NAA ratio compared to LI rats
(P5 0.02; 95% confidence interval [CI] [–53%, –2%]). Across
all rats, the mean GABA to NAA ratio was 0.22 (95% CI
[0.18, 0.25]).
To demonstrate that our findings were not confounded by
variation in NAA concentration, we also calculated GABA/Cho
and GABA/Cr ratios, which revealed the same significant con-
trast between HI and LI rats, specifically a 23% lower GABA/
Cho ratio in HI rats (P5 0.03; 95% CI [–47%, 0%] and a
26% lower GABA/Cr ratio (P5 0.03; 95% CI [–52%, 0%]).
FIGURE 2: Typical voxel placement for the MEGA-PRESS acqui-
sition showing horizontal, sagittal, and coronal sections, clock-
wise from left.
FIGURE 3: Typical spectra seen for MEGA-PRESS “off” (A),
MEGA-PRESS “on” (B) and the edited spectrum (C). Note the
expanded scale in (C). Line broadening of 7.5Hz has been
applied in (C) for clarity. Major peaks in (A) are labeled as Ins
(inositol), glutamine/glutamate (Glx), taurine (Tau), choline
(Cho), creatine, and phosphocreatine (Cr).
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Discussion
MEGA-PRESS spectra obtained were of high quality from
each rat, showing the feasibility of the method in rats at 4.7T.
We chose NAA to normalize the GABA signal for the least
error, as it has the strongest signal in the water-suppressed spectra.
NAA is usually considered a neuronal marker, and as such is a bet-
ter normalizing metabolite than water, in this case due to the like-
lihood of substantial variability in the fraction of ventricle present
in each voxel. This is particularly important for this study due to
the impact of variation in ventricle size and anatomy between rats
with close proximity to the large voxel used. Small anatomical var-
iations or errors in voxel placement could substantially increase
the water signal, leading to underestimation of metabolite concen-
trations. Furthermore, the NAA signal is derived from the
MEGA-PRESS data and not from a separate water reference scan
and so may be less susceptible to drift or motion occurring over
time. To guard against misinterpretation due to NAA changes
themselves, we calculated ratios based on creatine and choline and
found no substantial difference in the results.
A criticism of the MEGA-PRESS technique is the possi-
bility of coedited macromolecule signals that can have a sub-
stantial contribution to the measured GABA signal,13 arising
from spins at 3.0 ppm, which are coupled at 1.7 ppm and
overlapping with the measured GABA peak. It has been sug-
gested that this can be addressed by metabolite-nulled spectra
(eg, with an inversion time of 1 sec before acquisition)14,15
but that was not attempted here. There is some evidence that
metabolite-nulling reduces the reliability of GABA measure-
ments as it introduces sensitivity to motion and instabilities,
as the nulled baseline is not acquired in an interleaved fashion
with the MEGA-PRESS spectra.16 Despite this, we cannot be
certain that changes in macromolecule concentrations do not
contribute to the differences observed here. As GABA is pro-
duced from glutamate by glutamate decarboxylase (GAD65/
67), and this has been shown to be decreased in the ventral
striatum of HI rats,9 it is plausible that the lower signals in HI
rats were due to lower levels of endogenous GABA.
The measures of GABA concentration in rat brain
found here compare well with other MRS measurements
made using 13C doping (2.0mM17 at 11.7T), 1H/31P
(1.96 0.4mM14 at 8.4T). From studies primarily of rat
cortex, values measured by selective homonuclear polariza-
tion transfer at 11.7T18 are closer to the values found in
human brain, 1.26 0.1mM, with an ex vivo 13C value of
1.26mM found previously.19 The slightly larger values
FIGURE 4: Illustrative accepted transient (A), rejected transient
(B), and the mean spectrum from a typical subject for compari-
son (MEGAPRESS “off”).
FIGURE 5: Impulsivity scores measured in rats (A) showing stability of high premature responding rates over successive long intertrial
interval challenges (L1, L2, and L3) against successive baseline measures (S1, S2, . . ., S10). (B) GABA to NAA ratios for low-impulsive
(LI) and high-impulsive (HI) rats. Asterisk indicates significance at P < 0.05 and error bars show 1 SEM.
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implied by greater concentration ratios found in the present
study may be a reflection of the larger proportion (95%)
of GABAergic neurons of the rodent striatum20 or contami-
nation by coedited macromolecules.
Negative associations of GABA concentrations meas-
ured by MEGA-PRESS have been shown cortically in
human studies of impulsivity21 (see Ref. 22 or a more com-
prehensive review of 1H-MRS findings in neuropsychiatric
conditions). These common findings reinforce the value of
the translational methodology used here.
The limitations of this study are the ambiguity of
GABA signals with coedited macromolecules and the rela-
tively large voxel size compared to the anatomy of the small
structures known to be involved in the neurobiology of
impulsivity. Furthermore, as concentration ratios rather than
absolute GABA quantification was used, it is possible that
increases in other metabolites could explain the smaller
ratios obtained in HI rats. Although a significant reduction
in GABA ratios was shown in highly impulsive animals,
there is still some overlap in the values measured in weakly
impulsive animals, indicating that the GABA deficits alone
are not a sufficient determinant of impulsive behavior.
In conclusion, we have demonstrated that MEGA-
PRESS in rats is achievable in a reasonable time giving
high-quality spectra, and further that GABA concentration
ratios are significantly reduced in the ventral striatum of
highly impulsive rats compared with weakly impulsive rats.
It is possible that these findings can be used as the basis of
a translatable biomarker to investigate the brain mechanisms
of attention deficit / hyperactivity disorder, addiction, and
other disorders of impulse control in humans.
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